검색
Chemomab Therapeutics Ltd
CMMB관심 목록에 추가
1.410USD
+0.050+3.68%
종가 07-27 16:00（ET）시세는 15분 지연됩니다
40.61M시가총액
8.09P/E TTM
자세한 내용은 Chemomab Therapeutics Ltd 회사
Chemomab Therapeutics Ltd (formerly known as Anchiano Therapeutics Ltd) is a Israel-based clinical-stage biopharmaceutical company. The Company specializes in the development of patient oriented targeted therapy for the treatment of a wide range of fibrotic and inflammatory diseases with high unmet medical need among others. Its therapeutic and diagnostic technology, BC-819, constitutes a search paradigm for the targeted destruction of cancer cells with no effect on surrounding tissue and no observed side effects for long-term, safe treatment and prevention of cancer. The patient oriented targeted therapy approach is based on the identification of particular genes that are expressed only in tumors.
Chemomab Therapeutics Ltd 정보
종목 코드 CMMB
회사 이름Chemomab Therapeutics Ltd
상장일Aug 14, 2012
CEOMor (Adi)
직원 수16
유형Depository Receipt
회계 연도 종료Aug 14
주소Kiryat Atidim, Building 7
도시TEL AVIV-YAFO
증권 거래소NASDAQ OMX - NASDAQ BASIC
국가Israel
우편 번호6158002
전화972773310156
웹사이트https://www.chemomab.com/
종목 코드 CMMB
상장일Aug 14, 2012
CEOMor (Adi)
Chemomab Therapeutics Ltd의 회사 임원진
이름
이름/직위
직위
주식 보유
변동
Ms. Sigal Fattal, CPA
Ms. Sigal Fattal, CPA
Chief Financial Officer
Chief Financial Officer
14.48K
+95.59%
Dr. Nissim Darvish, M.D. Ph.D.
Dr. Nissim Darvish, M.D. Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
300.00
--
Mr. Neil Cohen
Mr. Neil Cohen
Independent Director
Independent Director
--
--
Dr. Adi Mor, Ph.D.
Dr. Adi Mor, Ph.D.
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Dr. Alan Charles Moses, M.D.
Dr. Alan Charles Moses, M.D.
Independent Director
Independent Director
--
--
Dr. Claude Nicaise, M.D.
Dr. Claude Nicaise, M.D.
Independent Director
Independent Director
--
--
Ms. Irina Koffler
Ms. Irina Koffler
Investor Relations
Investor Relations
--
--
Dr. David M. Weiner, M.D.
Dr. David M. Weiner, M.D.
Interim Chief Medical Officer
Interim Chief Medical Officer
--
--
Mr. Jack Lawler
Mr. Jack Lawler
Chief Development Officer
Chief Development Officer
--
--
이름
이름/직위
직위
주식 보유
변동
Ms. Sigal Fattal, CPA
Ms. Sigal Fattal, CPA
Chief Financial Officer
Chief Financial Officer
14.48K
+95.59%
Dr. Nissim Darvish, M.D. Ph.D.
Dr. Nissim Darvish, M.D. Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
300.00
--
Mr. Neil Cohen
Mr. Neil Cohen
Independent Director
Independent Director
--
--
Dr. Adi Mor, Ph.D.
Dr. Adi Mor, Ph.D.
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Dr. Alan Charles Moses, M.D.
Dr. Alan Charles Moses, M.D.
Independent Director
Independent Director
--
--
Dr. Claude Nicaise, M.D.
Dr. Claude Nicaise, M.D.
Independent Director
Independent Director
--
--
자주 묻는 질문
Chemomab Therapeutics Ltd의 상위 5대 주주는 누구인가요?
Chemomab Therapeutics Ltd의 상위 5대 주주는 다음과 같습니다: Ms. Sigal Fattal, CPA
Chemomab Therapeutics Ltd(CMMB)의 주식을 보유한 기관은 몇 개입니까?
2026Q1 기준으로, Chemomab Therapeutics Ltd의 주식을 보유한 기관은 총 33곳이며, 이들이 보유한 주식의 총 가치는 약 402.96K로 전체 발행 주식의 5.60%를 차지합니다. 이는 2025Q4 대비 -450971.00 증가한 수치입니다.